DNA adducts of ortho-toluidine in human bladder

References

• Airoldi L, Orsi F, Magagnotti C, Coda R, Randone D, Casetta G, Peluso M, Hautefeuille A, Malaveille C, Vineis P. 2002. Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies. Carcinogenesis 23:861–866.
   PubMedGoogle Scholar
• Baan R, Grosse Y, Straif K, Secretan B, El Ghissassi F., Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. 2009. A review of human carcinogens - Part F: chemical agents and related occupations. Lancet Oncol 10:1143–1144.
   PubMed Web of Science ®Google Scholar
• Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Cogliano V. 2008. Carcinogenicity of some aromatic amines, organic dyes, and related exposures. Lancet Oncol 9:322–323.
   PubMed Web of Science ®Google Scholar
• Bayraktar N, Kilic S, Bayraktar MR, Aksoy N. 2010. Lipid peroxidation and antioxidant enzyme activities in cancerous bladder tissue and their relation with bacterial infection: a controlled clinical study. J Clin Lab Anal 24:25–30.
   PubMed Web of Science ®Google Scholar
• Bessette EE, Spivack SD, Goodenough AK, Wang T, Pinto S, Kadlubar FF, Turesky RJ. 2010. Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry. Chem Res Toxicol 23:1234–1244.
   Google Scholar
• Branco PS, Antunes AMM, Marques MM, Chiarelli MP, Lobo AM, Prabhakar S. 1999. New syntheses of DNA adducts from methylated anilines present in tobacco smoke. Chem Res Toxicol 12:1223–1233.
   Google Scholar
• Brock WJ, Hundley SG, Lieder PH. 1990. Hepatic macromolecular binding and tissue distribution of ortho- and para-toluidine in rats. Toxicol Lett 54:317–325.
   Google Scholar
• Culp SJ, Roberts DW, Talaska G, Lang NP, Fu PF, Lay JO, Teitel CH, Snawder JE, von Tungeln LS, Kadlubar FF. 1997. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Mutat Res 378:97–112.
   PubMed Web of Science ®Google Scholar
• DeBord DG, Swearengin TF, Cheever KL, Booth-Jones AD, Wissinger LA. 1992. Binding characteristics of ortho-toluidine to rat hemoglobin and albumin. Arch Toxicol 66:231–236.
   Google Scholar
• DFG. 2006. List of MAK and BAT values 2006. D-69451 Weinheim, Germany: Wiley-VCH Verlag GmbH.
   Google Scholar
• Diaz Gómez MI, Fanelli SL, Delgado de Layño AM, Castro JA, Castro GD. 2006. Liver nuclear and microsomal CYP2E1-mediated metabolism of xenobiotics in rats chronically drinking an alcohol-containing liquid diet. Toxicol Ind Health 22:367–374.
   Google Scholar
• Dinsmore WW, Wyllie MG. 2009. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int 103:940–949.
   PubMed Web of Science ®Google Scholar
• Duan J-D, Jeffrey AM, Williams GM. 2008. Assessment of the medicines lidocaine, prilocaine and their metabolites, 2,6-dimethylaniline and 2-methylaniline, for DNA adduct formation in rat tissues. Drug Meta Dispos 36:1470–1475.
   Google Scholar
• El-Bayoumy K, Donahue JM, Hecht SS, Hoffmann D. 1986. Identification and quantitative determination of aniline and toluidines in human urine. Cancer Res 46:6064–6067.
   PubMed Web of Science ®Google Scholar
• Elmansouri A, Outzourhit A, Lachkar A, Hadik N, Abouelaoualim A, Achour ME, Oueriagli A, Ameziane EL. 2009. Influence of the counter ion on the properties of poly(o-toluidine) thin films and their Schottky diodes. Synth Met 159:292–297.
   Google Scholar
• Gaber K, Harréus UA, Matthias C, Kleinsasser NH, Richter E. 2007. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine. Toxicology 229:157–164.
   Google Scholar
• Gan J, Skipper PL, Gago-Dominguez M, Arakawa K, Ross RK, Yu MC, Tannenbaum SR. 2004. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer. J Natl Cancer Inst 96:1425–1431.
   PubMed Web of Science ®Google Scholar
• Grimmer G, Dettbarn G, Seidel A, Jacob J. 2000. Detection of carcinogenic aromatic amines in the urine of non-smokers. Sci Total Environ 247:81–90.
   PubMed Web of Science ®Google Scholar
• Grimmer G, Schneider D, Naujack K-W, Dettbarn G, Jacob J. 1995. Intercept-reactant method for the determination of aromatic amines in mainstream tobacco smoke. Beitr Tabakforsch Int 16:141–156.
   Google Scholar
• Haglund J, Henderson AP, Golding BT, Törnqvist M. 2002. Evidence for phosphate adducts in DNA from mice treated with 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Chem Res Toxicol 15:773–779.
   Google Scholar
• Heppel CW, Heling A-K, Richter E. 2009. Ultrasensitive method for the determination of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts by gas chromatography-high resolution mass spectrometry in mucosal biopsies of the lower esophagus. Anal Bioanal Chem 393:1525–1530.
   Google Scholar
• Hölzle D, Schlöbe D, Tricker AR, Richter E. 2007. Mass spectrometric analysis of 4-hydroxy-1-(3-pyridyl)-1-butanone-releasing DNA adducts in human lung. Toxicology 232:277–285.
   Google Scholar
• IARC. 2009. Overall evaluations of carcinogenicity to humans. http://monographs.iarc.fr/ENG/Classification/index.php
   Google Scholar
• IFOP. 2001. Azofarbstoffe, die in krebserzeugende Amine gemäß TRGS 614 (Ausgabe März 2001) spalten können. http://www.vci.de/template_downloads/tmp_VCIInternet/115196AzoTR614.pdf?DokNr=115196&p=101
   Google Scholar
• Jones CR, Sabbioni G. 2003. Identification of DNA adducts using HPLC/MS/MS following in vitro and in vivo experiments with arylamines and nitroarenes. Chem Res Toxicol 16:1251–1263.
   PubMed Web of Science ®Google Scholar
• Korinth G, Weiss T, Penkert S, Schaller KH, Angerer J, Drexler H. 2007. Percutaneous absorption of aromatic amines in rubber industry workers: impact of impaired skin and skin barrier creams. Occup Environ Med 64:366–372.
   PubMed Web of Science ®Google Scholar
• Kütting B, Göen T, Schwegler U, Fromme H, Uter W, Angerer J, Drexler H. 2009. Monoarylamines in the general population - A cross-sectional population-based study including 1004 Bavarian subjects. Int J Hyg Environ Health 212:298–309.
   PubMed Web of Science ®Google Scholar
• Kutzer C, Branner B, Zwickenpflug W, Richter E. 1997. Simultaneous solid-phase extraction and gas chromatographic-mass spectrometric determination of hemoglobin adducts from tobacco-specific nitrosamines and aromatic amines. J Chromatogr Sci 35:1–6.
   PubMed Web of Science ®Google Scholar
• Lao Y, Yu N, Kassie F, Villalta PW, Hecht SS. 2007a. Analysis of pyridyloxobutyl DNA adducts in F344 rats chronically treated with (R)- and (S)-N′-nitrosonornicotine. Chem Res Toxicol 20:246–256.
   PubMed Web of Science ®Google Scholar
• Lao Y, Yu N, Kassie F, Villalta PW, Hecht SS. 2007b. Formation and accumulation of pyridyloxobutyl DNA adducts in F344 rats chronically treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Chem Res Toxicol 20:235–245.
   PubMed Web of Science ®Google Scholar
• Lewalter J, Gries W. 2000. Haemoglobin adducts of aromatic amines: aniline, o-, m- and p-toluidine, o-anisidine, p-chloroaniline, α- and β-naphthylamine, 4-aminodiphenyl, benzidine, 4,4′-diaminodiphenylmethane, 3,3′-dichlorobenzidine. In: Greim H, editor. Analyses of Hazardous Substances in Biological Materials. Vol. 7. D-69469 Weinheim, Germany: Wiley-VCH Verlag GmbH. p 191–218.
   Google Scholar
• Lin D, Lay JO, Bryant MS, Malaveille C, Friesen M, Bartsch H, Lang NP, Kadlubar FF. 1994. Analysis of 4-aminobiphenyl-DNA adducts in human urinary bladder and lung by alkaline hydrolysis and negative ion gas chromatography-mass spectrometry. Environ Health Perspect 102 (Suppl.6):11–16.
   Google Scholar
• Lindenblatt N, Belusa L, Tiefenbach B, Schareck W, Olbrisch RR. 2004. Prilocaine plasma levels and methemoglobinemia in patients undergoing tumescent liposuction involving less than 2,000 ml. Aesth Plast Surg 28:435–440.
   Google Scholar
• Marques MM, Mourato LLG, Santos MA, Beland FA. 1996. Synthesis, characterization, and conformational analysis of DNA adducts from methylated anilines present in tobacco smoke. Chem Res Toxicol 9:99–108.
   PubMed Web of Science ®Google Scholar
• Martone T, Airoldi L, Magagnotti C, Coda R, Randone D, Malaveille C, Avanzi G, Merletti F, Hautefeuille A, Vineis P. 1998. 4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer. Int J Cancer 75:512–516.
   PubMed Web of Science ®Google Scholar
• Mourato LLG, Beland FA, Marques MM. 1999. 32P-postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies. Chem Res Toxicol 12:661–669.
   Google Scholar
• Neurath GB, Dünger M, Pein FG, Ambrosius D, Schreiber O. 1977. Primary and secondary amines in the human environment. Food Cosmet Toxicol 15:275–282.
   PubMedGoogle Scholar
• OECD. 2004. SIDS initial assessment report, o-toluidine. http://www.chem.unep.ch/irptc/sids/oecdsids/95534.pdf
   Google Scholar
• Palmiotto G, Pieraccini G, Moneti G, Dolara P. 2001. Determination of the levels of aromatic amines in indoor and outdoor air in Italy. Chemosphere 43:355–361.
   PubMedGoogle Scholar
• Patrianakos C, Hoffmann D. 1979. Chemical studies on tobacco smoke LXIV. On the analysis of aromatic amines in cigarette smoke. J Anal Toxicol 3:150–154.
   Web of Science ®Google Scholar
• Pliss GB. 2004. Experimental study of ortho-toluidine carcinogenicity. Voprosy onkologii 50:567–571.
   PubMedGoogle Scholar
• Randall KL, Argoti D, Paonessa JD, Ding Y, Oaks Z, Zhang Y, Vouros P. 2010. An improved liquid chromatography-tandem mass spectrometry method for the quantification of 4-aminobiphenyl DNA adducts in urinary bladder cells and tissues. J Chromatogr A 1217:4135–4143.
   Google Scholar
• Richter E, Branner B. 2002. Biomonitoring of exposure to aromatic amines: haemoglobin adducts in humans. J Chromatogr B 778:49–62.
   PubMed Web of Science ®Google Scholar
• Ricicki EM, Soglia JR, Teitel C, Kane R, Kadlubar F, Vouros P. 2005. Detection and quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry. Chem Res Toxicol 18:692–699.
   PubMedGoogle Scholar
• Riedel K, Scherer G, Engl J, Hagedorn H-W, Tricker AR. 2006. Determination of three carcinogenic aromatic amines in urine of smokers and nonsmokers. J Anal Toxicol 30:187–195.
   PubMed Web of Science ®Google Scholar
• Sabbioni G, Richter E. 1999. Aromatic amines, nitroarenes, and heterocyclic amines. In: Marquardt H, Schäfer SG, McClellan R, Welch F, editors. Toxicology. San Diego, CA, USA: Academic Press. p 729–174.
   Google Scholar
• Schütte-Borkovec K, Heppel CW, Heling A-K, Richter E. 2009. Analysis of myosmine, cotinine and nicotine in human toenail, plasma and saliva. Biomarkers 14:278–284.
   PubMed Web of Science ®Google Scholar
• Skipper PL, Kim MY, Sun H-LP Wogan, GN, Tannenbaum SR. 2010. Monocyclic aromatic amines as potential human carcinogens: old is new again. Carcinogenesis 31:50–58.
   PubMed Web of Science ®Google Scholar
• Stabbert R, Schäfer K-H, Biefel C, Rustemeier K. 2003. Analysis of aromatic amines in cigarette smoke. Rapid Commun Mass Spectrom 17:2125–2132.
   PubMed Web of Science ®Google Scholar
• Stepanov I, Hecht SS. 2005. Tobacco-specific nitrosamines and their pyridine-N-glucuronides in the urine of smokers and smokeless tobacco users. Cancer Epidemiol Biomarkers Prev 14:885–891.
   PubMed Web of Science ®Google Scholar
• Stiborova M, Miksanova M, Havlicek V, Schmeiser HH, Frei E. 2002. Mechanism of peroxidase-mediated oxidation of carcinogenic o-anisidine and its binding to DNA. Mutat Res 500:49–66.
   Google Scholar
• Stiborova M, Schmeiser HH, Breuer A, Frei E. 2001. Evidence for activation of carcinogenic o-anisidine by prostaglandin H synthase: 32P-postlabelling analysis of DNA adduct formation. Gen Physiol Biophys 20:267–279.
   Google Scholar
• Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Unruh L, Kadlubar FF, Bartsch H, Malaveille C, Vineis P. 1991. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomarkers Prev 1:61–66.
   PubMed Web of Science ®Google Scholar
• Thompson PA, DeMarini D, Kadlubar FF, McClure GY, Brooks LR, Green BL, Fares MY, Stone A, Josephy PD, Ambrosone CB. 2002. Evidence for the presence of mutagenic arylamines in human breast milk and DNA adducts in exfoliated breast ductal epithelial cells. Environ Mol Mutagen 39:134–142.
   PubMed Web of Science ®Google Scholar
• Tricker AR. 2006. Biomarkers derived from nicotine and its metabolites: a review. Beitr Tabakforsch Int 22:147–175.
   Google Scholar
• Ward EM, Sabbioni G, DeBord DG, Teass AW, Brown KK, Talaska GG, Roberts DR, Ruder AM, Streicher RP. 1996. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess. J Natl Cancer Inst 88:1046–1052.
   PubMed Web of Science ®Google Scholar
• Zayas B, Stillwell SW, Wishnok JS, Trudel LJ, Skipper P, Yu MC, Tannenbaum SR, Wogan GN. 2007. Detection and quantification of 4-ABP adducts in DNA from bladder cancer patients. Carcinogenesis 28:342–349.
   Google Scholar